These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 22248666)
1. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin. Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939 [TBL] [Abstract][Full Text] [Related]
3. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. Cui FD; Tao AJ; Cun DM; Zhang LQ; Shi K J Pharm Sci; 2007 Feb; 96(2):421-7. PubMed ID: 17051590 [TBL] [Abstract][Full Text] [Related]
4. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
5. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208 [TBL] [Abstract][Full Text] [Related]
6. Solvent mediated microstructures and release behavior of insulin from pH-sensitive nanoparticles. Wu ZM; Guo XD; Zhang LJ; Jiang W; Ling L; Qian Y; Chen Y Colloids Surf B Biointerfaces; 2012 Jun; 94():206-12. PubMed ID: 22356870 [TBL] [Abstract][Full Text] [Related]
7. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation. Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles. Yang J; Sun H; Song C Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional Composite Microcapsules for Oral Delivery of Insulin. Sun S; Liang N; Gong X; An W; Kawashima Y; Cui F; Yan P Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036045 [TBL] [Abstract][Full Text] [Related]
10. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Jain S; Rathi VV; Jain AK; Das M; Godugu C Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576 [TBL] [Abstract][Full Text] [Related]
11. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761 [TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Zhang Y; Wei W; Lv P; Wang L; Ma G Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083 [TBL] [Abstract][Full Text] [Related]
13. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738 [TBL] [Abstract][Full Text] [Related]
14. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
15. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443 [TBL] [Abstract][Full Text] [Related]
16. Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics. Sharma G; van der Walle CF; Ravi Kumar MN Int J Pharm; 2013 Jan; 440(1):99-110. PubMed ID: 22227604 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
18. Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration. Socha M; Sapin A; Damgé C; Maincent P Drug Deliv; 2009 Nov; 16(8):430-6. PubMed ID: 19839787 [TBL] [Abstract][Full Text] [Related]
19. Novel PLGA-based nanoparticles for the oral delivery of insulin. Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248 [TBL] [Abstract][Full Text] [Related]
20. Application of mesoscale simulation to explore the aggregate morphology of pH-sensitive nanoparticles used as the oral drug delivery carriers under different conditions. Wang Y; Chen BZ; Liu YJ; Wu ZM; Guo XD Colloids Surf B Biointerfaces; 2017 Mar; 151():280-286. PubMed ID: 28038414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]